Pure Global
NCT06269237

Point of Care Test of LTA Level in Tear Fluid, Measured With a POCT Test, in DE Patients Following IPL Treatment

He Eye Hospital·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Dry Eye
Drug/Device/Intervention
M22
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
He Eye Hospital
Timeline & enrollment
Phase
N/A
Start date
Feb 22, 2024
End date
Jul 01, 2024
Enrollment
30 participants
Primary outcome

LTA,Non-invasive tear break-up time (NITBUT)

Summary

To quantify and compare tear levels of Intense pulsed light (IPL) and traditional dry eye
 clinical tests in dry eye patients before and after Intense pulsed light (IPL) treatment.

ICD-10 classifications
Ocular painAvulsion of eyeOther corneal deformitiesCorneal ulcerDry mouth, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06269237
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06269237 through Pure Global AI's free database. This phase not specified trial is sponsored by He Eye Hospital and is currently Not yet recruiting. The study focuses on Dry Eye. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.